Home » Posts tagged 'bango plc'
Tag Archives: bango plc
H&T Group HAT expects profit before tax for the full year to 31st December will be above market expectations following a strong fourth quarter in pawnbroking, with quality watches doing particularly well. The pledge book increased by11.6% on a year ago following the higher gold price and the personal loans book rocketed by 94.7%, after the introduction of a lower interest rate, long term product
Micro Focus International MCRO is increasing its interim dividend by 16.4% for the half year to the 31st October and afrer completion of its complex acquisition of HPE Software on the 1st September. The interim figures include results from HPE. as from 1st September. Revenue rose by 80.7% and pre tax profit by 28.7% ( or 33.8% at constant currency rates). Basic earnings per share fell by 9.5% but on an adjusted basis rose by 16%. Micro Focus is confident that its industry leading margins will ensure that it can deliver on its strategy which will be enhanced by further acquisitions.
System 1 group SYS1 (formerly Brainjuicer) After a fall of 9% in first half gross profit, trading in quarter three has continued to be worse than expected and expectations for gross profit for the full year are that it will show a 20% decline on the previous year. Profit before tax for the full year will be only a little over breakeven point. The cas position is however sound with a balance of £4.6m and no debt
Bango BGO saw total End User Spend for the year to 31st December, grow by by 105%, from £132m to 271m. It has also now entered into partnership with Netflix to launch carrier billing for Netflix customers in Mexico, making carrier billing available to over 12 million Mexican customers.
Mattioli Woods MTW The six months to the end of November has produced another period of strong and sustainable growth with EBITDA margins for the first half substantially ahead of the 20% target.
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.
|ST Rec. changed|
|Michelmersh Brick Holdings||Neutral||Buy|
|Deltex Medical Group||Buy||Neutral|
|Industrial Good & Services||From||To|
|21st Century Technology||Neutral||Sell|
|Oil & Gas – Explorers||From||To|
|Borders & Southern Petroleum||Neutral||Buy|
|Oil & Gas – Producers||From||To|
|ST Rec. changed|
|Aerospace & Defence||From||To|
|Building Materials & Fittings||From||To|
|Morgan Sindall Group||Neutral||Sell|
|Engineering & Machinery||From||To|
|JD Sports Fashion||Sell||Neutral|
|Leisure & Hotels||From||To|
|Media & Entertainment||From||To|
|Oil & Gas||From||To|
|Royal Dutch Shell B||Neutral||Buy|
|Pharmaceuticals & Biotechnology||From||To|
|Real Estate – REIT||From||To|
|The Local Shopping REIT||Sell||Neutral|
|Town Centre Securities||Sell||Neutral|
|Speciality & Other Finance||From||To|
|Aberdeen Asset Management||Buy||Neutral|
|Cable & Wireless Communications||Neutral||Sell|
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
|DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.
The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.
Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.
Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.
No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.
Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.
Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.
Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.
Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.